Lung cancer in HIV-positive patients

Journal of Thoracic Oncology

Volumn 5, Issue 11, 2010, Pages 1864-1871

  Pakkala, Suchita ^a   Ramalingam, Suresh S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Antiretroviral therapy; HIV; Lung cancer; NSCLC

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; PROTEIN E6; TRANSACTIVATOR PROTEIN;

ANOREXIA; BK VIRUS; CACHEXIA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; CLINICAL TRIAL; COUGHING; DEMOGRAPHY; DYSPNEA; ESOPHAGITIS; FEVER; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ABUSE; LUNG CANCER; NIGHT SWEAT; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; TACHYCARDIA; TACHYPNEA; THORAX PAIN; VIRUS CARCINOGENESIS; VIRUS LOAD; WART VIRUS; WEIGHT REDUCTION;

EID: 78149468193     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181f387fd     Document Type: Article

References (90)

1. Kaposi's sarcoma and pneumocystis pneumonia among homosexual men-New York City and California. MMWR 1981;30:305-308.
2. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
3. Rabkin CS. AIDS and cancer in the era of highly active antiretroviral therapy (HAART). Eur J Cancer 2001;37:1316-1319.
4. Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007;99:962-972.
5. Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989- 2002. Clin Infect Dis 2004;39:1380-1384.
6. Crum-Cianflone N, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009;23:41-50.
7. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20:1645-1654.
8. Long, JL, Engels EA, Moore RD, et al. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS 2008;22:489-496.
9. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008;148:728-736.
10. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425-432.
11. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92:1823-1830.
12. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338: 853-860.
13. Nutankalva L, Wutoh AK, McNeil J, et al. Malignancies in HIV: preand post-highly active antiretroviral therapy. J Natl Med Assoc 2008; 100:817-820.
14. Bonnet F, Burty C, Lewden C, et al. Changes in cancer mortality among HIV-infected patients: the Mortalite' 2005 Survey. Clin Infect Dis 2009;48:633-639.
15. Palella FJJMD, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
16. Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York city. Ann Intern Med 2006;145:397-406.
17. Smit C, Geskus R, Walker S, et al. Cascade Collaboration. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006;20:741-749.
18. Monforte A, Abrams D, Pradier C, et al. Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008;22:2143-2153.
19. Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalite 2000 and 2005" Surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008;48:590-598.
20. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41:194-200.
21. World Health Organization. Cancer Fact Sheet 2009 [cited October 7, 2009], 2009. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/ index.html. Accessed October 7, 2009.
22. Bertolaccini L, Lybéris P, Soncini S, et al. Clinical characteristic lung cancer in HIV-infected patients. Cancer Ther 2008;6:903-906.
23. Alshafie MT, Donaldson B, Oluwole SF. Human immunodeficiency virus and lung cancer. Br J Surg 1997;84:1068-1071.
24. Lavolé A, Chouaïd C, Baudrin L, et al. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer 2009;65:345-350.
25. Brock MV, Hooker CM, Engels EA, et al. Delayed Diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr 2006;43: 47-55.
26. Tirelli U, Spina M, Sandri S, et al. Lung carcinoma in 36 patients with human immunodeficiency virus infection. Cancer 2000;88:563-569.
27. Guiguet M, Boué F, Cadranel J, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009;10:1152-1159.
28. Bedimo RJ, McGinnis KA, Dunlap M, et al. Incidence of non-AIDSdefining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 2009;52:203-208.
29. Newcomb-Fernandez J. Cancer in the HIV-infected population. Res Initiat Treat Action 2003;9:5-13.
30. Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDSdefining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003;21:3447-3453.
31. Grulich AE, Li Y, McDonald A, et al. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002;16:1155-1161.
32. Dal Maso L, Polesel J, Serraino D, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009;100:840-847.
33. Shiels MS, Cole SR, Kirk GD, et al. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009;52:611-622.
34. Grulich AE, Wan X, Law MG, et al. Risk of cancer in people with AIDS. AIDS 1999;13:839-843.
35. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009;27:884-890.
36. Frisch M, Biggar RJ, Engels EA, et al. AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285:1736-1745.
37. Engels EA, Brock MV, Chen J, et al. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 2006;24:1383-1388.
38. Dal Maso L, Polesel J, Serraino D, et al. Lung cancer in persons with AIDS in Italy, 1985-1998. AIDS 2003;17:2117-2119.
39. Parker MS, Leveno DM, Campbell TJ, et al. AIDS-related bronchogenic carcinoma: fact or fiction? Chest 1998;113:154-161.
40. Hessol NAM, Seaberg EC, Preston-Martin S, et al. Cancer risk among participants in the Women's Interagency HIV study. J Acquir Immune Defic Syndr 2004;36:978-985.
41. Phelps RM, Smith DK, Heilig CM, et al. Cancer incidence in women with or at risk for HIV. Int J Cancer 2001;94:753-757.
42. Sridhar KS, Flores MR, Raub WA Jr, et al. Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest 1992;102:1704-1708.
43. Karp J, Profeta G, Marantz PR, et al. Lung cancer in patients with immunodeficiency syndrome. Chest 1993;103:410-413.
44. Gallagher B, Wang Z, Schymura MJ, et al. Cancer incidence in New York state acquired immunodeficiency syndrome patients. Am J Epidemiol 2001;154:544-556.
45. Silverberg MJ, Chao C, Leyden WA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009;23: 2337-2345.
46. Vyzula R, Remick SC. Lung cancer in patients with HIV-infection. Lung Cancer 1996;15:325-339.
47. Bower M, Powles T, Nelson M, et al. HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 2003;17:371-375.
48. Spano J-P, Massiani MA, Bentata M, et al. Lung cancer in patients with HIV infection and review of literature. Med Oncol 2004;21:109-115.
49. Braun MA, Killam DA, Remick SC, et al. Lung cancer in patients seropositive for human immunodeficiency virus. Radiology 1990;175: 341-343.
50. Irwin L, Begandy MK, Moore TM. Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome. Ann of Int Med 1984;100:158.
51. Reynolds P, Saunders LD, Layefsky ME, et al. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco. Am J Epidemiol 1993;137:19-30.
52. Koblin B, Hessol NA, Zauber AG, et al. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978- 1990. Am J Epidemiol 1996;144:916-923.
53. Cooksley CD, Hwang LY, Waller DK, et al. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 1999;10:792-802.
54. Chaturvedi AK, Pfeiffer RM, Chang L, et al. Elevated risk of lung cancer among people with AIDS. AIDS 2007;21:207-213.
55. Polesel J, Franceschi S, Suligoi B, et al. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010;127:1437-1445.
56. Silverberg M, Lau B, D'Souza G, et al. Trends in cumulative incidence of cancer among HIV-infected patients in North America. Seventeenth Conference on Retroviruses & Opportunistic Infections (CROI), San Francisco, CA, February 16-19, 2010. Abstract 758.
57. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007;165:1143-1153.
58. Serraino D, Piselli P, Busnach G, et al. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007;43:2117-2123.
59. Kirk GD, Merlo C, O' Driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007;45:103-110.
60. Silverberg MJ, Neuhaus J, Bower M, et al. Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 2007;21: 1957-1963.
61. Levine AM, Seaberg EC, Hessol NA, et al. HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol 2010;28:1514-1519.
62. Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS 2003;17:1179-1193.
63. Benard A, Bonnet F, Tessier JF, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS 2007;21:458-468.
64. Reynolds NR. Cigarette smoking and HIV: more evidence for action. AIDS Educ Prevent 2009;21:106-121.
65. Fishman J, Schwartz DS, Sais GJ, et al. Bronchogenic carcinoma in HIV-positive patients: findings on chest radiographs and CT scans. AJR Am J Roentgenol 1995;164:57-61.
66. Sigel K, Wisnivesky J, Justice A, et al. HIV Infection is an independent risk factor for lung cancer. Seventeenth Conference on Retroviruses and Opportunistic Infections (CROI), San Francisco, CA, February 16-19, 2010. Abstract 30.
67. Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003;89:94-100.
68. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59-67.
69. Mbulaiteye SM, Biggar RJ, Goedert JJ, et al. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 2003;32:527-533.
70. Tenholder MF, Jackson HD. Bronchogenic carcinoma in patients seropositive for human immunodeficiency virus. Chest 1993;104:1049-1053.
71. Silverberg M, Xu L, Chao C, et al. Immunodeficiency, HIV RNA levels, and risk of non-AIDS-defining cancers. Conference on Retroviruses &Opportunistic Infections (CROI), San Francisco, CA, February 16-19, 2010. Abstract 28.
72. De Falco G, Bellan C, Lazzi S, et al. Interaction between HIV-1 Tat and pRb2//p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms. Oncogene 2003;22:6214-6219.
73. Stebbing J, Wickenden C, Castellano L, et al. No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancer. AIDS 2010;24:1221-1223.
74. Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009;65:13-18.
75. HSU NY, Cheng YW, Chan IP, et al. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Oncol Rep 2009;21:81-87.
76. Rezazadeh AMD, Laber DA, Ghim SJ, et al. The role of human papilloma virus in lung cancer: a review of the evidence. [Review]. Am J Med Sci 2009;338:64-67.
77. Chan TK, Aranda CP, Rom WN. Bronchogenic carcinoma in young patients at risk for acquired immunodeficiency syndrome. Chest 1993; 103:862-864.
78. Hakimian R, Fang H, Thomas L, et al. Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol 2007;2:268-272.
79. Centers for Disease Control. HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:1073-1076.
80. Bazot M, Cadranel J, Khalil A, et al. Computed tomographic diagnosis of bronchogenic carcinoma in HIV-infected patients. Lung Cancer 2000;28:203-209.
81. Spina M, Sandri S, Serraino D, et al. Therapy of non-small-cell lung cancer (NSCLC) in patients with HIV infection. Ann Oncol 1999; 10(Suppl 5):S87-S90.
82. Massera F, Rocco G, Rossi G, et al. Pulmonary resection for lung cancer in HIV-positive patients with low (<200 lymphocytes/mm3) CD4+ count. Lung Cancer 2000;29:147-149.
83. Powles T, Thirwell C, Newsom-Davis T, et al. Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? Br J Cancer 2003;89:457-459.
84. Makinson A, Pujol JL, Le Moing V, et al. Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer. J Thorac Oncol 2010;5:562-571.
85. Burke M, Furman A, Hoffman M, et al. Lung cancer in patients with HIV infection: is it AIDS-related? HIV Med 2004;5:110-114.
86. Meguid RA, Hooker CM, DeAngelis JA, et al. Outcomes of lung cancer surgery in HIV-positive smokers: initial findings. J Am Coll Surg 2007;205:S24.
87. Bruyand M, Thiébaut R, Lawson-Ayayi S, et al. Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis 2009;49:1109-1116.
88. Lewden CMDP, Chene G, Morlat P, et al. HIV-Infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007;46:72-77.
89. Prosperi MCF, Cozzi-Lepri A, Castagna A, et al. Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian Cohort Study. Clin Infect Dis 2010;50:1316-1321.
90. Ruiz M. Early lung cancer detection in HIV: the role of CT screening in high risk cases. HIV Clin 2010;22:1-5.